Concord Medical Services Limited Statistics
Share Statistics
Concord Medical Services Limited has 4.53M shares outstanding. The number of shares has increased by -90.73% in one year.
Shares Outstanding | 4.53M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | -90.73% |
Owned by Institutions (%) | n/a |
Shares Floating | 3.67M |
Failed to Deliver (FTD) Shares | 121 |
FTD / Avg. Volume | 1.67% |
Short Selling Information
The latest short interest is 11.40K, so 0.28% of the outstanding shares have been sold short.
Short Interest | 11.40K |
Short % of Shares Out | 0.28% |
Short % of Float | 0.33% |
Short Ratio (days to cover) | 2.14 |
Valuation Ratios
The PE ratio is -1.2 and the forward PE ratio is -33.8.
PE Ratio | -1.2 |
Forward PE | -33.8 |
PS Ratio | 0.66 |
Forward PS | null |
PB Ratio | -0.17 |
P/FCF Ratio | -0.91 |
PEG Ratio | n/a |
Enterprise Valuation
Concord Medical Services Limited has an Enterprise Value (EV) of 3.58B.
EV / Earnings | -12.02 |
EV / Sales | 6.66 |
EV / EBITDA | -10.4 |
EV / EBIT | -7.73 |
EV / FCF | -9.13 |
Financial Position
The company has a current ratio of 0.32, with a Debt / Equity ratio of -1.44.
Current Ratio | 0.32 |
Quick Ratio | 0.3 |
Debt / Equity | -1.44 |
Total Debt / Capitalization | 327.13 |
Cash Flow / Debt | -0.09 |
Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is 0.14% and return on capital (ROIC) is -9.59%.
Return on Equity (ROE) | 0.14% |
Return on Assets (ROA) | -0.05% |
Return on Capital (ROIC) | -9.59% |
Revenue Per Employee | 739.20K |
Profits Per Employee | -409.43K |
Employee Count | 727 |
Asset Turnover | 0.09 |
Inventory Turnover | 15.22 |
Taxes
Income Tax | 24.57M |
Effective Tax Rate | -0.04 |
Stock Price Statistics
The stock price has increased by -52.86% in the last 52 weeks. The beta is -0.27, so Concord Medical Services Limited's price volatility has been lower than the market average.
Beta | -0.27 |
52-Week Price Change | -52.86% |
50-Day Moving Average | 6.2 |
200-Day Moving Average | 6.53 |
Relative Strength Index (RSI) | 38.33 |
Average Volume (20 Days) | 7.23K |
Income Statement
In the last 12 months, Concord Medical Services Limited had revenue of $537.40M and earned -$297.66M in profits. Earnings per share was $-68.14.
Revenue | 537.40M |
Gross Profit | -76.61M |
Operating Income | -462.99M |
Net Income | -297.66M |
EBITDA | -344.16M |
EBIT | -462.99M |
Earnings Per Share (EPS) | -68.14 |
Balance Sheet
The company has $58.14M in cash and $3.30B in debt, giving a net cash position of -$3.24B.
Cash & Cash Equivalents | 58.14M |
Total Debt | 3.30B |
Net Cash | -3.24B |
Retained Earnings | -4.06B |
Total Assets | 6.62B |
Working Capital | -1.14B |
Cash Flow
In the last 12 months, operating cash flow was -$276.47M and capital expenditures -$115.70M, giving a free cash flow of -$392.17M.
Operating Cash Flow | -276.47M |
Capital Expenditures | -115.70M |
Free Cash Flow | -392.17M |
FCF Per Share | -89.77 |
Margins
Gross margin is -14.26%, with operating and profit margins of -86.15% and -55.39%.
Gross Margin | -14.26% |
Operating Margin | -86.15% |
Pretax Margin | -103.39% |
Profit Margin | -55.39% |
EBITDA Margin | -64.04% |
EBIT Margin | -86.15% |
FCF Margin | -72.98% |
Dividends & Yields
CCM does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | -1376.57% |
FCF Yield | -1747.95% |
Analyst Forecast
Currently there are no analyst rating for CCM.
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Stock Splits
The last stock split was on Jul 30, 2024. It was a backward split with a ratio of 1:10.
Last Split Date | Jul 30, 2024 |
Split Type | backward |
Split Ratio | 1:10 |
Scores
Altman Z-Score | -1.25 |
Piotroski F-Score | 2 |